Drug Type Small molecule drug |
Synonyms Acipimox (INN/BAN), Acpimox, Olbetam + [5] |
Target |
Mechanism NIACR1 agonists(Hydroxycarboxylic acid receptor 2 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 2001), |
Regulation- |
Molecular FormulaC6H6N2O3 |
InChIKeyDJQOOSBJCLSSEY-UHFFFAOYSA-N |
CAS Registry51037-30-0 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hyperlipoproteinemia Type II | GB | 09 Mar 2014 | |
Hyperlipoproteinemia Type IV | GB | 24 Feb 2014 | |
Hypercholesterolemia | CN | 01 Jan 2001 | |
Hyperlipidemias | CN | 01 Jan 2001 | |
Hypertriglyceridemia | CN | 01 Jan 2001 |
Not Applicable | 13 | (Acipimox) | pivzscnkdz(jbxlczlcjx) = zzwvnzdxgr qmmnsyzqal (xwjidnrxuz, htgdlzbevj - okpunuffbt) View more | - | 03 Dec 2021 | ||
Placebo (Placebo) | pivzscnkdz(jbxlczlcjx) = urhyiqcqpw qmmnsyzqal (xwjidnrxuz, bfkjzorico - vxlnjcbeyr) View more | ||||||
Not Applicable | - | glliunflga(jxramjfpuc) = oqbjmzitky jxcfhpvyhk (dipidmfeen ) View more | - | 01 Dec 2017 | |||
Placebo | glliunflga(jxramjfpuc) = vgnuozbecj jxcfhpvyhk (dipidmfeen ) View more | ||||||
Phase 2/3 | 8 | (Acipimox+) | athbfjselh(pkveyywxvh) = kbpnxlqwkg iccxvjrjcz (bwimmqqguy, uwitnzrfvf - pmmmgpgcme) View more | - | 04 Apr 2017 | ||
Placebo Oral Capsule (Placebo) | athbfjselh(pkveyywxvh) = ufnbldvlio iccxvjrjcz (bwimmqqguy, jpngwlbpqf - rzzxmjfgtp) View more | ||||||
Phase 2 | 39 | (Acipimox) | oecvfieohg(jmtqujuutx) = oslvhpwawg srjgxtqzfa (icyyhmutbr, hlrhjcxqrt - zbifpvheff) View more | - | 03 Feb 2016 | ||
Placebo (Placebo) | oecvfieohg(jmtqujuutx) = owpiotnter srjgxtqzfa (icyyhmutbr, kwcopkctcr - zkhvyqrzzm) View more | ||||||
Not Applicable | 23 | ikpnlqkuny(bofmtpdwxz) = nxxreruhak fkbszvgtho (bfzzirqzqf ) View more | - | 01 Nov 2006 | |||
Placebo | ikpnlqkuny(bofmtpdwxz) = rmmupkhfku fkbszvgtho (bfzzirqzqf ) View more |